1138 Investors following Plethico Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Buy Plethico Pharma, target of Rs 569: Emkay
Emkay Research has maintained a but rating on Plethico Pharma with a target price of Rs 569. The stock is currently trading at 9.0x FY08E EPS of Rs 43.8 and 7.7x FY09E EPS of Rs 51.5.
Emkay Research has maintained a but rating on Plethico Pharma with a target price of Rs 569 in its April 3, 2008 research report. "The stock is currently trading at 9.0x FY08E EPS of Rs 43.8 and 7.7x FY09E EPS of Rs 51.5. It is trading at 7.5x FY08E and 5.6x FY09E EV/EBDITA. We believe these valuations are attractive and offer excellent long term investment opportunity. We believe there is still room for upward revision of target price. We maintain 'BUY' on the stock with a target price of Rs 569" , says Emkay's research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.